Medicare is set to negotiate with manufacturers on 15 drugs in an effort to lower their prices for consumers nationwide. The ...

The best Medicare plans for cancer patients are a Medigap Plan G from AARP and a Medicare Part D plan from Wellcare. Alternatively, if your cancer diagnosis means you can't qualify for Medigap, choose ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Prosecutors allege Adam Wayne Owens violated an anti-kickback statute in a scheme to provide genetic cancer testing for ...

Shares of Guardant Health (NASDAQ:GH) have increased by 5.0% in premarket trading Tuesday following the company's ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Cancer treatment costs about $150,000 per patient.  In 2015, spending for cancer treatment and care in the United States was estimated at $183 billion | Cancer ...

Cancer treatment access differs significantly between traditional Medicare and Medicare Advantage  (MA), according to new research from the University of Colorado Cancer Center.

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

A new study on high-cost drug use in colorectal and non-small cell lung cancer patients found that those with Medicare Advantage plans received less expensive cancer drugs compared to those on ...